Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

95

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent Treg–microglia crosstalk

Nasal anti-CD3 monoclonal antibody ameliorates traumati...

118

Targeting SARM1: from inhibition for neuroprotection to activation for neuroablation

Targeting SARM1: from inhibition for neuroprotection to...

78

The Nobel Prize in Physics 2025

The Nobel Prize in Physics 2025

68